Notably, the GT75 DNA aptamer developed by Bosutti et al. targets the eEF1A1-actin complex in invasive PCa cells, leading to reduced cell viability and increased cell death, suggesting eEF1A1 as a potential therapeutic target for advanced PCa (Bosutti et al., 2022). Here, EEF1A1 is linked to posterior cortical atrophy.